ARQULE INC Contracts & Agreements

First Amendment to Agreement and Plan of Merger, dated December 17, 2019, among ArQule, Inc., Merck Sharp & Dohme Corp. and Argon Merger Sub, Inc (Filed With SEC on December 17, 2019)

Agreement and Plan of Merger, dated December 6, 2019, among ArQule, Inc., Merck Sharp & Dohme Corp. and Argon Merger Sub, Inc (Filed With SEC on December 9, 2019)

1.1Underwriting Agreement dated June 24, 2019 (Filed With SEC on June 25, 2019)

Separation of Employment Agreement, dated March 13, 2019, between the Company and Robert Weiskopf (Filed With SEC on May 1, 2019)

Fifth Amendment to Employment Agreement, dated as of March 29, by and between the Company and Paolo Pucci (Filed With SEC on May 1, 2019)

Sixth Amendment to Employment Agreement, dated as of March 29, by and between the Company and Peter S. Lawrence (Filed With SEC on May 1, 2019)

Sixth Amendment to Employment Agreement, dated as of March 29, by and between the Company and Brian Schwartz (Filed With SEC on May 1, 2019)

Letter Agreement, dated April 11, 2019, by and between the Company and Marc Schegerin (Filed With SEC on May 1, 2019)

Form of Incentive Stock Option Agreement to the Companys 2014 Equity Incentives Plan (Filed With SEC on March 7, 2019)

Form of Non-Statutory Stock Option Agreement to the Companys 2014 Equity Incentives Plan (Filed With SEC on March 7, 2019)

License Agreement by and between the Company and Basilea Pharmaceutica International Limited, dated April 16, 2018 (Filed With SEC on August 1, 2018)

Exhibit 1.1Underwriting Agreement dated July 10, 2018, by and between ArQule, Inc. and Leerink Partners LLC, as representative for the several underwriters listed therein (Filed With SEC on July 13, 2018)

License Agreement, dated February 2, 2018, by and among ArQule, Inc., Sinovant Sciences Ltd. and Roivant Sciences Ltd (Filed With SEC on March 5, 2018)

Warrant dated February 16, 2018 (Filed With SEC on February 22, 2018)

Second Amendment to Loan and Security Agreement between and among ArQule, Inc. and Oxford Finance LLC dated February 16, 2018 (Filed With SEC on February 22, 2018)

Master Services Agreement, dated July 20, 2017, by and between the Company and ARUP Laboratories, Inc (Filed With SEC on November 9, 2017)

Scope of Work #1 to Master Services Agreement, dated July 20, 2017, by and between the Company and ARUP Laboratories, Inc (Filed With SEC on November 9, 2017)

Scope of Work #2 to Master Services Agreement, dated July 20, 2017, by and between the Company and ARUP Laboratories, Inc (Filed With SEC on November 9, 2017)

Form of Warrant (Filed With SEC on November 8, 2017)

Form of Securities Purchase Agreement (Filed With SEC on November 8, 2017)

Form of Warrant (Filed With SEC on October 16, 2017)

Form of Securities Purchase Agreement (Filed With SEC on October 16, 2017)

ARQULE, INC. 2014 EQUITY INCENTIVES PLAN PERFORMANCE STOCK OPTION AGREEMENT (Filed With SEC on April 10, 2017)

FOURTH AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on April 10, 2017)

FIFTH AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on April 10, 2017)

FOURTH AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on April 10, 2017)

WARRANT TO PURCHASE STOCK (Filed With SEC on January 10, 2017)

LOAN AND SECURITY AGREEMENT (Filed With SEC on January 10, 2017)

ArQule, Inc. Common Stock ($0.01 par value per share) Capital on Demand™ SalesAgreement (Filed With SEC on October 26, 2016)

THIRD AMENDMENT TO EMPLOYMENTAGREEMENT (Filed With SEC on April 14, 2016)

FOURTH AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on April 14, 2016)

THIRD AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on April 14, 2016)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on February 29, 2016)

Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Triple asterisks denote omissions. COLLABORATIVE RESEARCH AND DEVELOPMENT AGREEMENT... (Filed With SEC on August 5, 2015)

SECOND AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on March 11, 2013)

THIRD AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on March 11, 2013)

SECOND AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on March 11, 2013)

ARQULE, INC. (a Delaware corporation) 7,150,000Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 12, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on March 1, 2012)

LICENSE AND CO-COMMERCIALIZATION AGREEMENT BY AND BETWEEN ARQULE, INC. and DAIICHI SANKYO CO., LTD November 8, 2011 [*] = CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND... (Filed With SEC on March 1, 2012)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on February 27, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on February 24, 2012)

AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on February 24, 2012)

ARQULE,INC. (Filed With SEC on August 4, 2011)

ARQULE, INC. (a Delaware corporation) 7,000,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 25, 2011)

AGREEMENTON MILESTONE PAYMENTS AND ROYALTIES (Filed With SEC on August 7, 2009)

COLLABORATIVE RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT between ARQULE, INC. and DAIICHI SANKYO CO., LTD November 7, 2008 (Filed With SEC on March 6, 2009)

LICENSE, CO-DEVELOPMENT AND CO-COMMERCIALIZATION AGREEMENT BY AND BETWEEN ARQULE, INC. and DAIICHI SANKYO CO., LTD December 18, 2008 (Filed With SEC on March 6, 2009)

Internal Use Only (Filed With SEC on November 10, 2008)

Separation Agreement and General Release (Filed With SEC on July 24, 2008)

Second Amendment to Employment Agreement (Filed With SEC on April 18, 2008)

EXHIBIT B-1 ARQULE, INC. AMENDED AND RESTATED 1994 EQUITY INCENTIVE PLAN (Filed With SEC on April 18, 2008)

Amendment to Employment Agreement (Filed With SEC on October 10, 2007)

EXCLUSIVELICENSE AGREEMENT (Filed With SEC on August 7, 2007)

ARQULE, INC. 7,000,000 Shares Common Stock ($0.01 par valueper Share) UNDERWRITINGAGREEMENT (Filed With SEC on June 15, 2007)

RESEARCHAGREEMENT (Filed With SEC on March 7, 2007)

SCIENTIFICADVISORY BOARD CHAIRMAN AGREEMENT (Filed With SEC on February 1, 2007)

SeparationAgreement and General Release (Filed With SEC on February 1, 2007)

EXHIBITB (Filed With SEC on August 1, 2006)

Separation Agreement and General Release (Filed With SEC on April 27, 2006)

EMPLOYMENT AGREEMENT (Filed With SEC on April 18, 2006)

EX-21 Amended and Restated Lease (Filed With SEC on August 5, 2005)

EX-10.1 Form of Agreement of Purchase and Sale (Filed With SEC on May 6, 2005)

EX-10.2 Form of Lease (Filed With SEC on May 6, 2005)

Ex-10.9 Amended and Restated Research and Development Agreement (Filed With SEC on March 16, 2005)

Ex-10.12 Amend. No.1 to Compound Supply and License Agreement (Filed With SEC on March 16, 2005)

Ex-10.49 Strategic Alliance dated 4/1/2004 (Filed With SEC on May 7, 2004)

AMENDED AND RESTATED R&D LICENSE AGREEMENT (Filed With SEC on March 12, 2004)

R&D AGREEMENT DATED 11/11/1997 (Filed With SEC on March 12, 2004)

TERMINATION AGREEMENT DATED 6/30/2000 (Filed With SEC on March 12, 2004)

EMPLOYMENT AGREEMENT/ STEPHEN A. HILL/ 1/1/2004 (Filed With SEC on March 12, 2004)

EMPLOYMENT AGREEMENT/ J. DAVID JACOBS/ 1/1/2004 (Filed With SEC on March 12, 2004)

EMPLOYMENT AGREEMENT/ LOUISE MAWHINNEY/ 1/1/2004 (Filed With SEC on March 12, 2004)

AMENDMENT TO COLLABORATION AGREEMENT/ 2/12/2004 (Filed With SEC on March 12, 2004)

AGREEMENT AND PLAN OF REORGANIZATION (Filed With SEC on November 12, 2003)

AGREEMENTAND PLAN OF MERGER OF CYCLIS PHARMACEUTICALS, INC. WITH AND INTO ARQULE, INC. (Filed With SEC on November 12, 2003)

FOURTH LOANMODIFICATION AGREEMENT (Filed With SEC on November 12, 2003)

EMPLOYMENT AGREEMENT (Filed With SEC on November 12, 2003)

THIRD LOAN MODIFICATIONAGREEMENT (Filed With SEC on May 15, 2003)

Ex-10.1 Amended and Restated Reseach, Development (Filed With SEC on May 14, 2001)

Category

Industry

Companies

Contracts

ARQULE INC Contracts & Agreements